Oxana Beskrovnaya
2021
In 2021, Oxana Beskrovnaya earned a total compensation of $2.9M as Chief Scientific Officer at Dyne Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $201,527 |
|---|---|
| Option Awards | $479,195 |
| Salary | $406,875 |
| Stock Awards | $1,820,317 |
| Other | $1,038 |
| Total | $2,908,952 |
Beskrovnaya received $1.8M in stock awards, accounting for 63% of the total pay in 2021.
Beskrovnaya also received $201.5K in non-equity incentive plan, $479.2K in option awards, $406.9K in salary and $1K in other compensation.
Rankings
In 2021, Oxana Beskrovnaya's compensation ranked 4,546th out of 12,415 executives tracked by ExecPay. In other words, Beskrovnaya earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,546 out of 12,415 | 63rd |
Division Manufacturing | 1,879 out of 5,505 | 66th |
Major group Chemicals And Allied Products | 783 out of 2,375 | 67th |
Industry group Drugs | 697 out of 2,096 | 67th |
Industry Pharmaceutical Preparations | 498 out of 1,546 | 68th |
Source: SEC filing on April 22, 2022.
Beskrovnaya's colleagues
We found two more compensation records of executives who worked with Oxana Beskrovnaya at Dyne Therapeutics in 2021.